• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Development of group A streptococcal vaccine using mucosal immune system.

Research Project

Project/Area Number 08670900
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Pediatrics
Research InstitutionKagoshima University

Principal Investigator

YOSHINAGA Masao  Faculty of Medicine, Kagoshima University, Associate Professor, 医学部, 助教授 (10145469)

Co-Investigator(Kenkyū-buntansha) NOMURA Yuichi  University Hospital, Kagoshima University, Assistant Professor, 医学部・附属病院, 講師 (90237884)
奥 章三  鹿児島大学, 医学部・附属病院, 助手 (80224145)
Project Period (FY) 1996 – 1998
Project Status Completed (Fiscal Year 1998)
Budget Amount *help
¥2,200,000 (Direct Cost: ¥2,200,000)
Fiscal Year 1998: ¥500,000 (Direct Cost: ¥500,000)
Fiscal Year 1997: ¥800,000 (Direct Cost: ¥800,000)
Fiscal Year 1996: ¥900,000 (Direct Cost: ¥900,000)
Keywordsgroup A streptococci / M protein / peptide / vaccine / mucosal immunity / 鼻咽腔免疫 / 溶レン菌
Research Abstract

Recent studies by overlapping synthetic peptides have revealed that major epitopes for IgG antibodies existed in the sequences of the C region of the streptococcal M protein) and that some of them may be a combination of a single break (b-turn and b-sheet, called as the turn, hereafter) in conformation in each C repeal and an adjacent sequence (a-helix) before or after the turns. The sequence just after the turn shows the homology with mammalian myosin. Purpose of the present study is to clarify the role of the combination of the turn and the adjacent sequence to develop a streptococcal vaccine candidate that shows better immunogenicity, no cross-reactivity with myosin, and greater opsonophagocytic reactivity. Peptides were synthesized based on the M6 molecules The M6 M protein has 2 turns in the C region. Each peptide was made to have a combination of a turn and an adjacent sequence, before, after, or both of the turn, then 6 peptides were synthesized. Each peptide was administered to … More 3 rabbits and the serum was purified to a peptide-specific antibody with affinity columns. The antibodies with the combination of the turn and the sequence after the turn showed the greatest immunogenicity, and the difference in one amino acid in the turn affected the immunogenicity of these peptides. On the other hand, the peptides with the sequence after the turn showed non-specific cross-reactivity with skeletal myosin, but not to cardiac myosin. The cross-reactivity was not due to the sequence homology between the C region and myosin. The peptides with a combination of the turn and the sequence before the turn did not induce any cross-reactivity with myosin. All anti peptide specific antibodies showed good opsonophagocytic activity when high antibody titers to the C region were obtained. These data suggest that the combination of the turn and the adjacent sequence before the turn will be a candidate of choice for a streptococcal vaccine, because we are concerned about the possibility of evoking non-specific cross-reactivity of anti C region antibody with myosin. Less

Report

(4 results)
  • 1998 Annual Research Report   Final Research Report Summary
  • 1997 Annual Research Report
  • 1996 Annual Research Report
  • Research Products

    (20 results)

All Other

All Publications (20 results)

  • [Publications] Maeno N,et al.: "Anti-M protein antibody in poststreptococcal reactive arthritis." J Rheumatol. in press.

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nishi J,et al.: "Prevalence of penicillin-resistant viridans streptococci in the oral flora of Japanese children at risk for infective endocarditis." Circulation. 99(9). 1274-1275 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshinaga M,et al.: "Human secretory immune response to streptcoccal M protein: Identification of secretory IgA epitope in the exposed conserved region." Adv Exp Med.Biol. 418. 913-915 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Zabriskie JB,et al.: "Phagocytic, serological, and protective properties of streptcoccal Group A carbohydrate antibodies." Adv Exp Med Biol. 418. 917-919 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mogi A,et al.: "Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases." Pediatr Infect Dis J. 16(12). 1140-1144 (1997)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Wahid MR,etal.: "Mitral regurgitation may be related with previous streptococcal infection" Eur J Pediatr. 155. 168-172 (1996)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Maeno N,Yoshinaga M,Takei S,Nishi J,Imanaka H,Wahid MR,et al: "Anti-M protein antibody in poststreptococcal reactive arthritis." J Rheumatol. (in press).

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Nishi J,Yoshinaga M,Nomura Y: "Prevalence of penicillin-resistant viridans streptococci in the oral flora of Japanese children at risk for infective endocarditis." Circulation. 99. 1274-1275 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshinaga M,Miyata M,Fischetti VA: "Human secretory immune response to streptcoccal M protein : Identification of secretory IgA epitope in the exposed conserved region." Adv Exp Med Biol. 418. 913-915 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Zabriskie JB,Poon-King T,Blake MS,Michon F,Yoshinaga M: "Phagocytic, serological, and protective properties of streptcoccal Group A carbohydrate antibodies." Adv Exp Med Biol. 418. 917-919 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Mogi A,Nishi J,Yoshinaga M,Harada H,Narahara S,Kawakami K,et al: "Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases." Pediatr Infect Dis J. 16 (12). 1140-1144 (1997)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Wahid MR,Yoshinaga M,Nomura Y,Oku S,Takei S,Narahara S: "Mitral regurgitation may be related with previous streptococcal infection." Eur J Pediatr. 155. 168-172 (1996)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      1998 Final Research Report Summary
  • [Publications] Yoshinaga M,et al.: "Human secretory immune response to streptcoccal M protein:Identification of secretory IgA epitope in the exposed conserved region." Adv Exp Med Biol,. 418. 913-915 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Zabriskie JB,et al.: "Phagocytic,serological,and protective properties of streptcoccal Group A carbohydrate antibodies." Adv Exp Med Biol,. 418. 917-919 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Mogi A,et al.: "Increased prevalence of penicillin-resistant viridans group streptococci in Japanese children with upper respiratory infection treated by beta-lactam agents and in those with oncohematologic diseases" Pediatr Infect Dis J,. 16(12). 1140-1144 (1997)

    • Related Report
      1998 Annual Research Report
  • [Publications] Nishi J,Yoshinaga M,Nomura Y.: "Prevalence of penicillin-resistant viridans streptococci in the oral flora of Japanese children at risk for infective endocarditis." Circulation. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Maeno N,et al.: "Anti-M protein antibody in poststreptococcal reactive arthritis." J Rheumatol. (in press).

    • Related Report
      1998 Annual Research Report
  • [Publications] Masao Yoshinaga et al: "Human secretory immune response to streptococcal M protein:Identification of a secretory IgA epitope in the exposed conserved region" Advances in Experimental Medicine and Biology. 418. 913-916 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] John B Zabriskie et al: "Phagocytic serological and protective properties of streptococcal Group A carbohydrate antibodies" Advances in Experimental Medicine and Biology. 418. 917-920 (1997)

    • Related Report
      1997 Annual Research Report
  • [Publications] Yoshinaga M, Miyata K, Fischetti VA: "Human secretory immune response to streptococcal M protein : Identification of a secretory IgA epitope in the exposed conserved region." In Streptococci and Host. Horaud T et al ed. Plenum Press, New York. (in press). (1997)

    • Related Report
      1996 Annual Research Report

URL: 

Published: 1996-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi